Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 158,334 | reported | 01 Sept 2016 | tx 10+120,000−71,666 |
| ZEVRA THERAPEUTICS, INC. | 30,000 | reported | 04 Jun 2026 | tx 5+178,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2026 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 12 Sept 2025 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 20,000 | 7.89 USD | |
| 29 May 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 39,200 | 0.00 USD | deriv |
| 20 Jan 2024 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 58,800 | 0.00 USD | deriv |
| 01 Sept 2016 | SALE | Travere Therapeutics, Inc. | 8,750 | 16.24 USD | |
| 01 Jun 2016 | SALE | Travere Therapeutics, Inc. | 8,750 | 17.75 USD | |
| 19 May 2016 | GRANT_AWARD | Travere Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Mar 2016 | SALE | Travere Therapeutics, Inc. | 8,750 | 14.35 USD | |
| 09 Dec 2015 | SALE | Travere Therapeutics, Inc. | 8,750 | 20.83 USD | |
| 06 Oct 2015 | SALE | Travere Therapeutics, Inc. | 4,798 | 19.58 USD | |
| 06 Oct 2015 | SALE | Travere Therapeutics, Inc. | 2,823 | 20.45 USD | |
| 06 Oct 2015 | SALE | Travere Therapeutics, Inc. | 1,129 | 21.61 USD | |
| 01 Jul 2015 | GRANT_AWARD | Travere Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 26 Jun 2015 | SALE | Travere Therapeutics, Inc. | 27,916 | 32.70 USD |